J&J/McNeil Divests E.P.T. Pregnancy Tests To Insight Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson divests another non-core consumer health brand – e.p.t. pregnancy tests – as the remediation of its OTC business continues.
You may also be interested in...
New Products In Brief
P&G gets clinical on plaque prevention with Crest Pro-Health collection; Salonpas touts topical pain-relief trio; fertility testing made easy with SpermCheck device, e.p.t. Ovulation Calculator; TUMS line freshens up; more New Products In Brief.
Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs
Insight Pharmaceutical expanded its women’s health care footprint with the acquisition of the Monistat North American portfolio from McNeil Consumer Healthcare.
Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs
Insight Pharmaceutical expanded its women’s health care footprint with the acquisition of the Monistat North American portfolio from McNeil Consumer Healthcare.